1
Paul Glue, David L Cutler, Melton B Affrime: Polyethylene glycol modified interferon therapy. Schering Corporation, Jaye P McLaughlin, June 1, 1999: US05908621 (91 worldwide citation)

A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.


2

3
David L Cutler, Melton B Affrime: Continuous low-dose cytokine infusion therapy. Schering Corporation, Lerner David Littenberg Krumholz & Mentlik, October 8, 2002: US06461605 (40 worldwide citation)

A method is provided for treating conditions that are susceptible of treatment with a cytokine wherein the undesirable side effects normally associated with cytokine administration are diminished or eliminated. The method comprises continuously administering a low dose of a cytokine to an individual ...


4

5
Melton B Affrime, Christopher R Banfield, Samir K Gupta, Desmond Padhi: Treating allergic and inflammatory conditions. Schering Corporation, Schering Plough Patent Group, July 29, 2008: US07405223 (3 worldwide citation)

A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e.g. seasonal allergic rhinitis, perennial allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e.g. 2× ...


6
Melton B Affrime, Christopher R Banfield, Samir K Gupta, Desmond Padhi: Treating allergic and inflammatory conditions. Schering Corporation, Barry H Jacobsen, March 8, 2011: US07902208

A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e.g. seasonal allergic rhinitis, perennial allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e.g. 2× ...


7
Melton B Affrime, Christopher R Banfield, Samir K Gupta, Desmond Padhi: Use of desloratadine for treating allergic and inflammatory conditions. Covington & Burling, July 15, 2004: US20040138247-A1

The use of desloratadine for the preparation of a medicament for treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages in a human while avoiding the food effect associated with non-sedating antihistamines, e.g., loratadine or fexofenadine is d ...


8
Melton B Affrime, Christopher R Banfield, Samir K Gupta, Desmond Padhi: Treating allergic and inflammatory conditions. Covington & Burling, October 23, 2008: US20080262018-A1

A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e.g. seasonal allergic rhinitis, perennial allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e.g. 2× ...


9
Melton B Affrime, Christopher R Banfield, Samir K Gupta: Treating allergic and inflammatory conditions. Schering Plough Corporation, Patent Department, February 14, 2002: US20020019409-A1

A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e.g. seasonal allergic rhinitis, pernninal allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e.g. 2× ...


10
Melton B Affrime, Christhoper R Banfield, Samir K Gupta: Treating allergic and inflammatory conditions. Schering Plough Corporation, Patent Department, January 2, 2003: US20030004179-A1

The use of desloratadine for the preparation of a medicament for treating and/or preventing an allergic and inflammatory condition of the skin or upper and lower airway passages in a pediatric patient and a pediatric pharmaceutical composition effective for such treating and/or preventing which comp ...